home / stock / swtuy / swtuy quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $24.38 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $24.38 | $N/A | $N/A | 0 | 04-11-2019 |
$ | $N/A | $24.38 | $N/A | $N/A | 0 | 04-10-2019 |
$ | $24.38 | $24.38 | $24.38 | $24.38 | 200 | 04-09-2019 |
$ | $24.75 | $24.67 | $24.75 | $24.67 | 700 | 04-08-2019 |
$ | $N/A | $24.67 | $N/A | $N/A | 0 | 04-05-2019 |
$ | $N/A | $24.67 | $N/A | $N/A | 0 | 04-04-2019 |
$ | $N/A | $24.67 | $N/A | $N/A | 0 | 04-03-2019 |
$ | $24.67 | $24.67 | $24.67 | $24.67 | 20,219 | 04-02-2019 |
$ | $N/A | $23.29 | $N/A | $N/A | 0 | 04-01-2019 |
$ | $N/A | $23.29 | $N/A | $N/A | 0 | 03-29-2019 |
$ | $23.54 | $23.29 | $23.74 | $23.29 | 439 | 03-28-2019 |
$ | $N/A | $23.47 | $N/A | $N/A | 20 | 03-27-2019 |
$ | $N/A | $23.47 | $N/A | $N/A | 0 | 03-26-2019 |
$ | $N/A | $23.47 | $N/A | $N/A | 0 | 03-25-2019 |
$ | $23.90 | $23.47 | $23.90 | $23.47 | 1,174 | 03-22-2019 |
$ | $24.37 | $24.37 | $24.37 | $24.37 | 158 | 03-21-2019 |
$ | $N/A | $23.61 | $N/A | $N/A | 68 | 03-20-2019 |
$ | $N/A | $23.61 | $N/A | $N/A | 0 | 03-19-2019 |
$ | $23.61 | $23.61 | $23.61 | $23.61 | 700 | 03-18-2019 |
$ | $N/A | $21.62 | $N/A | $N/A | 0 | 03-15-2019 |
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Bio S/Adr Company Name:
SWTUY Stock Symbol:
OTCMKTS Market:
In March, Sanofi (NASDAQ: SNY) and its Sweden-based partner Sobi (OTC: SWTUY) announced positive phase 3 clinical trial results for efanesoctocog alfa, their jointly developed drug candidate for severe hemophilia A. The two companies expect to begin submitting applicatio...
Shares of drugmaker Dova Pharmaceuticals (NASDAQ: DOVA) rose by 86.5% in September, according to data provided by S&P Global Market Intelligence . This added to Dova's big gains in 2019, piggybacking on a June jump of 59.9%. Year to date, the company's shares have skyrocketed 271.2%. A...
Shares of Dova Pharmaceuticals (NASDAQ: DOVA) , a biopharmaceutical company focused on rare blood-based diseases, leapt higher following a generous buyout offer. The European rare-disease drugmaker Sobi (OTC: SWTUY) will acquire Dova for up to $29 per share, which is around 45% ...